Pardon Our Progress

The BRIMR website is under construction.

Status of 2022 Rankings

The 2022 federal fiscal year ended on 30 Sept 2022.  NIH released its final catalogue of 2022 awards on December 22.

BRIMR has now prepared a modified draft version of those NIH data, which will serve as the basis of all our 2022 rankings. It will remain available for 4 weeks of public review. Access the draft file here.

We encourage users to download these data and provide any feedback, corrections, or suggestions via email to , following our instructions for submitting corrections.  All proposed corrections must be received by BRIMR before 6:00 PM EST on Sunday 5 February 2023.  BRIMR expects to release its final 2022 rankings in early February 2023.

For questions or to request ranking tables from prior years please feel free to contact us at

Protein Kinase Inhibitors

There are 73 FDA-approved small molecule protein kinase inhibitors as of 7 December 2022. View them here.

Visitors since 7 August 2010
Total Visitors